Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205

Amit Kumar Chaudhary, Goutam Mondal, Virender Kumar, Krishna Kattel, Ram I Mahato

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Treatment of pancreatic cancer with gemcitabine (GEM) is limited due to its rapid plasma metabolism and development of chemoresistance. MicroRNA (miRNA) regulates cancer stem cell (CSC) maintenance and induces chemoresistance in cancer cells. In this study, we observed differential downregulation of miR-205 (miR-205-5p) in human pancreatic cancer tissues and cells. Compared to GEM-sensitive MIA PaCa-2 cells, miR-205 was highly downregulated in GEM-resistant MIA PaCa-2R cells. Lentivirus-mediated overexpression of miR-205 inhibits MIA PaCa-2R cell proliferation after GEM-treatment. Further investigation confirmed that miR-205 alone significantly reduces the proliferation of CSCs and tumor growth in mouse models. However, miR-205 in combination with GEM was more efficient in reducing the proliferation of CSCs and 3D spheroids. Moreover, miR-205 overexpressing MIA PaCa-2R cells induced orthotopic tumor growth was significantly inhibited after intravenous administration of GEM-conjugated methoxy poly(ethylene glycol)-block-poly(2-methyl-2-carboxyl-propylene carbonate)-graft-gemcitabine-graft-dodecanol (mPEG-b-PCC-g-GEM-g-DC) (mPEG-b-PCC-g-GEM-g-DC) polymeric micelles. Also, a reduction in CSCs, EMT and chemoresistance markers was observed in miR-205 overexpressing MIA PaCa-2R cells. Immunohistochemical analysis of orthotopic tumors showed a decrease in drug resistance protein caveolin-1 and cell proliferation marker Ki-67 in combination treatment. Overall, our findings suggest that miR-205 resensitizes GEM-resistant pancreatic cancer cells to GEM and acts as a tumor suppressor miRNA.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalCancer Letters
Volume402
DOIs
StatePublished - Aug 28 2017

Fingerprint

gemcitabine
MicroRNAs
Pancreatic Neoplasms
Neoplasms
Dodecanol
Down-Regulation
Cell Proliferation
Transplants
Caveolin 1
Lentivirus
Ethylene Glycol
Neoplastic Stem Cells

Keywords

  • Chemoresistance
  • Drug delivery
  • Gemcitabine
  • MicroRNA
  • Pancreatic cancer
  • Tumor suppressor

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205. / Chaudhary, Amit Kumar; Mondal, Goutam; Kumar, Virender; Kattel, Krishna; Mahato, Ram I.

In: Cancer Letters, Vol. 402, 28.08.2017, p. 1-8.

Research output: Contribution to journalArticle

Chaudhary, Amit Kumar ; Mondal, Goutam ; Kumar, Virender ; Kattel, Krishna ; Mahato, Ram I. / Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205. In: Cancer Letters. 2017 ; Vol. 402. pp. 1-8.
@article{766cd27e8b47478cab67d814bbda74da,
title = "Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205",
abstract = "Treatment of pancreatic cancer with gemcitabine (GEM) is limited due to its rapid plasma metabolism and development of chemoresistance. MicroRNA (miRNA) regulates cancer stem cell (CSC) maintenance and induces chemoresistance in cancer cells. In this study, we observed differential downregulation of miR-205 (miR-205-5p) in human pancreatic cancer tissues and cells. Compared to GEM-sensitive MIA PaCa-2 cells, miR-205 was highly downregulated in GEM-resistant MIA PaCa-2R cells. Lentivirus-mediated overexpression of miR-205 inhibits MIA PaCa-2R cell proliferation after GEM-treatment. Further investigation confirmed that miR-205 alone significantly reduces the proliferation of CSCs and tumor growth in mouse models. However, miR-205 in combination with GEM was more efficient in reducing the proliferation of CSCs and 3D spheroids. Moreover, miR-205 overexpressing MIA PaCa-2R cells induced orthotopic tumor growth was significantly inhibited after intravenous administration of GEM-conjugated methoxy poly(ethylene glycol)-block-poly(2-methyl-2-carboxyl-propylene carbonate)-graft-gemcitabine-graft-dodecanol (mPEG-b-PCC-g-GEM-g-DC) (mPEG-b-PCC-g-GEM-g-DC) polymeric micelles. Also, a reduction in CSCs, EMT and chemoresistance markers was observed in miR-205 overexpressing MIA PaCa-2R cells. Immunohistochemical analysis of orthotopic tumors showed a decrease in drug resistance protein caveolin-1 and cell proliferation marker Ki-67 in combination treatment. Overall, our findings suggest that miR-205 resensitizes GEM-resistant pancreatic cancer cells to GEM and acts as a tumor suppressor miRNA.",
keywords = "Chemoresistance, Drug delivery, Gemcitabine, MicroRNA, Pancreatic cancer, Tumor suppressor",
author = "Chaudhary, {Amit Kumar} and Goutam Mondal and Virender Kumar and Krishna Kattel and Mahato, {Ram I}",
year = "2017",
month = "8",
day = "28",
doi = "10.1016/j.canlet.2017.05.007",
language = "English (US)",
volume = "402",
pages = "1--8",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205

AU - Chaudhary, Amit Kumar

AU - Mondal, Goutam

AU - Kumar, Virender

AU - Kattel, Krishna

AU - Mahato, Ram I

PY - 2017/8/28

Y1 - 2017/8/28

N2 - Treatment of pancreatic cancer with gemcitabine (GEM) is limited due to its rapid plasma metabolism and development of chemoresistance. MicroRNA (miRNA) regulates cancer stem cell (CSC) maintenance and induces chemoresistance in cancer cells. In this study, we observed differential downregulation of miR-205 (miR-205-5p) in human pancreatic cancer tissues and cells. Compared to GEM-sensitive MIA PaCa-2 cells, miR-205 was highly downregulated in GEM-resistant MIA PaCa-2R cells. Lentivirus-mediated overexpression of miR-205 inhibits MIA PaCa-2R cell proliferation after GEM-treatment. Further investigation confirmed that miR-205 alone significantly reduces the proliferation of CSCs and tumor growth in mouse models. However, miR-205 in combination with GEM was more efficient in reducing the proliferation of CSCs and 3D spheroids. Moreover, miR-205 overexpressing MIA PaCa-2R cells induced orthotopic tumor growth was significantly inhibited after intravenous administration of GEM-conjugated methoxy poly(ethylene glycol)-block-poly(2-methyl-2-carboxyl-propylene carbonate)-graft-gemcitabine-graft-dodecanol (mPEG-b-PCC-g-GEM-g-DC) (mPEG-b-PCC-g-GEM-g-DC) polymeric micelles. Also, a reduction in CSCs, EMT and chemoresistance markers was observed in miR-205 overexpressing MIA PaCa-2R cells. Immunohistochemical analysis of orthotopic tumors showed a decrease in drug resistance protein caveolin-1 and cell proliferation marker Ki-67 in combination treatment. Overall, our findings suggest that miR-205 resensitizes GEM-resistant pancreatic cancer cells to GEM and acts as a tumor suppressor miRNA.

AB - Treatment of pancreatic cancer with gemcitabine (GEM) is limited due to its rapid plasma metabolism and development of chemoresistance. MicroRNA (miRNA) regulates cancer stem cell (CSC) maintenance and induces chemoresistance in cancer cells. In this study, we observed differential downregulation of miR-205 (miR-205-5p) in human pancreatic cancer tissues and cells. Compared to GEM-sensitive MIA PaCa-2 cells, miR-205 was highly downregulated in GEM-resistant MIA PaCa-2R cells. Lentivirus-mediated overexpression of miR-205 inhibits MIA PaCa-2R cell proliferation after GEM-treatment. Further investigation confirmed that miR-205 alone significantly reduces the proliferation of CSCs and tumor growth in mouse models. However, miR-205 in combination with GEM was more efficient in reducing the proliferation of CSCs and 3D spheroids. Moreover, miR-205 overexpressing MIA PaCa-2R cells induced orthotopic tumor growth was significantly inhibited after intravenous administration of GEM-conjugated methoxy poly(ethylene glycol)-block-poly(2-methyl-2-carboxyl-propylene carbonate)-graft-gemcitabine-graft-dodecanol (mPEG-b-PCC-g-GEM-g-DC) (mPEG-b-PCC-g-GEM-g-DC) polymeric micelles. Also, a reduction in CSCs, EMT and chemoresistance markers was observed in miR-205 overexpressing MIA PaCa-2R cells. Immunohistochemical analysis of orthotopic tumors showed a decrease in drug resistance protein caveolin-1 and cell proliferation marker Ki-67 in combination treatment. Overall, our findings suggest that miR-205 resensitizes GEM-resistant pancreatic cancer cells to GEM and acts as a tumor suppressor miRNA.

KW - Chemoresistance

KW - Drug delivery

KW - Gemcitabine

KW - MicroRNA

KW - Pancreatic cancer

KW - Tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=85019885086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019885086&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2017.05.007

DO - 10.1016/j.canlet.2017.05.007

M3 - Article

VL - 402

SP - 1

EP - 8

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

ER -